The Wyss Institute and Astrazeneca will apply the Institute's advances in the development and validation of human organs-on-chips (such as the one shown here) to develop new animal versions. Credit: Alison Reggio/Wyss Institute
Today the Wyss Institute for Biologically Inspired Engineering at Harvard University and AstraZeneca announced a collaboration that will leverage the Institute's Organs-on-Chips technologies to better predict safety of drugs in humans.
Human Organs-on-Chips are composed of a clear, flexible polymer about the size of a computer memory stick, and contain hollow microfluidic channels lined by living human cells—allowing researchers to recreate the physiological and mechanical functions of the organ, and to observe what happens in real time. The goal is to provide more predictive and useful measures of the efficacy and safety of potential new drugs in humans—which could represent an important step in reducing the need for traditional animal testing.
The collaboration with AstraZeneca will apply the Institute's advances in the development and validation of human organs-on-chips to develop new animal versions. These animal organs-on-chips will be tested alongside the human models to further understand the extent to which drug safety results in animals can predict how an investigational drug might impact humans. The testing of a potential new medicine on animals is a small but necessary step in bringing this medicine to market. Regulators require safety data from animal studies before giving the required approval to test a new medicine in humans. However, animal tests do not always accurately predict what will happen in humans.
"Comparing human and animal organs-on-chips is an exciting example of what we call 'predictive science,' in which we harness the power of technology to better understand how a medicine might ultimately impact patients and in some cases speed the delivery of innovative new medicines," said Stefan Platz, Vice President Drug Safety and Metabolism at AstraZeneca. "The Wyss Institute's technology could play a critical role in both improving patient safety and reducing the need for animal testing."
In February, Wyss Founding Director Don Ingber, M.D., Ph.D., who leads the Organs-on-Chips research program, received the prestigious 3Rs Prize from the UK's National Centre for the Replacement, Refinement and Reduction of Animals in Research for the lung-on-a-chip. In March the Society of Toxicology awarded him the Leading Edge in Basic Science Award for his "seminal scientific contributions and advances to understanding fundamental mechanisms of toxicity."
"This collaboration with AstraZeneca will help us to validate this approach as a potential alternative to animal testing by carrying out direct comparisons between organ chips containing cells from animals versus humans in organ-mimicking environments," said Ingber. "If successful, this effort should lead to ways to streamline the drug development process and more effectively predict the safety of drugs and chemicals in humans."
Explore further: Team to use 'organ-on-a-chip' microdevices to evaluate therapies for lethal radiation exposure
Medical Xpress on facebook
Related Stories
Team to use 'organ-on-a-chip' microdevices to evaluate therapies for lethal radiation exposure
Aug 12, 2013
A team at the Wyss Institute for Biologically Inspired Engineering at Harvard University has received a $5.6 million grant award from the United States Food and Drug Administration (FDA) to use its Organs-on-Chips ...
Lung-on-a-Chip wins prize for potentially reducing need for animal testing
Feb 26, 2013
In a London ceremony today, Wyss Founding Director Don Ingber, M.D., Ph.D., received the NC3Rs 3Rs Prize from the UK's National Centre for the Replacement, Refinement and Reduction of Animals in Research ...
Scientists integrating multiple organ-on-chip systems to mimic the whole human body
Aug 11, 2012
The Wyss Institute for Biologically Inspired Engineering at Harvard University today announced that it has entered into a Cooperative Agreement worth up to $37 million with the Defense Advanced Research ...
Army, academia develop human-on-a-chip technology
Sep 30, 2013
There was a time when the thought of manufacturing organs in the laboratory was science fiction, but now that science is a reality. Army Scientists at the Edgewood Chemical Biological Center and academia ...
'Lung-on-a-chip' sets stage for next wave of research to replace animal testing
Nov 07, 2012
Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University have mimicked pulmonary edema in a microchip lined by living human cells, as reported today in the journal Science Tr ...
Recommended for you
New estimates give updated count of Iraq war deaths between 2003 and 2011
16 hours ago
During the U.S.-led invasion and occupation of Iraq from 2003 to 2011, for every three people killed by violence, two died as a result of the collapse of the infrustructure that supports health care, clean ...
J&J 3Q net rises slightly on higher medicine sales
17 hours ago
A big jump in prescription drug sales and continued recovery of Johnson & Johnson's beleaguered consumer health business in the third quarter helped the health care giant overcome a new problem: slumping sales of its medical ...
Radiation experts confirm polonium on Arafat clothing
Oct 14, 2013
Swiss radiation experts have confirmed they found traces of polonium on clothing used by Yasser Arafat which "support the possibility" the veteran Palestinian leader was poisoned.
Buttocks-enhancing procedures please patients, small study finds
Oct 11, 2013
(HealthDay)—Beyonce, Kim Kardashian and Jennifer Lopez have put ample backsides on some women's wish lists. And what nature forgot, plastic surgeons can provide with a buttocks augmentation.
Checklist developed to cut radiation exposure in children
Oct 11, 2013
(HealthDay)—A checklist has been developed to minimize radiation exposure to children during radiography; the checklist has been published in the October issue of the Journal of the American College of ...
Execution drugs spark controversy as supplies dwindle
Oct 11, 2013
The United States is turning to new drugs for lethal injections as supplies of the current standard dwindle, sparking lawsuits from death row prisoners that the changes will cause undue suffering.
User comments
© Medical Xpress 2011-2013, Phys.org network
The Wyss Institute and Astrazeneca will apply the Institute's advances in the development and validation of human organs-on-chips (such as the one shown here) to develop new animal versions. Credit: Alison Reggio/Wyss Institute
Today the Wyss Institute for Biologically Inspired Engineering at Harvard University and AstraZeneca announced a collaboration that will leverage the Institute's Organs-on-Chips technologies to better predict safety of drugs in humans.
Human Organs-on-Chips are composed of a clear, flexible polymer about the size of a computer memory stick, and contain hollow microfluidic channels lined by living human cells—allowing researchers to recreate the physiological and mechanical functions of the organ, and to observe what happens in real time. The goal is to provide more predictive and useful measures of the efficacy and safety of potential new drugs in humans—which could represent an important step in reducing the need for traditional animal testing.
The collaboration with AstraZeneca will apply the Institute's advances in the development and validation of human organs-on-chips to develop new animal versions. These animal organs-on-chips will be tested alongside the human models to further understand the extent to which drug safety results in animals can predict how an investigational drug might impact humans. The testing of a potential new medicine on animals is a small but necessary step in bringing this medicine to market. Regulators require safety data from animal studies before giving the required approval to test a new medicine in humans. However, animal tests do not always accurately predict what will happen in humans.
"Comparing human and animal organs-on-chips is an exciting example of what we call 'predictive science,' in which we harness the power of technology to better understand how a medicine might ultimately impact patients and in some cases speed the delivery of innovative new medicines," said Stefan Platz, Vice President Drug Safety and Metabolism at AstraZeneca. "The Wyss Institute's technology could play a critical role in both improving patient safety and reducing the need for animal testing."
In February, Wyss Founding Director Don Ingber, M.D., Ph.D., who leads the Organs-on-Chips research program, received the prestigious 3Rs Prize from the UK's National Centre for the Replacement, Refinement and Reduction of Animals in Research for the lung-on-a-chip. In March the Society of Toxicology awarded him the Leading Edge in Basic Science Award for his "seminal scientific contributions and advances to understanding fundamental mechanisms of toxicity."
"This collaboration with AstraZeneca will help us to validate this approach as a potential alternative to animal testing by carrying out direct comparisons between organ chips containing cells from animals versus humans in organ-mimicking environments," said Ingber. "If successful, this effort should lead to ways to streamline the drug development process and more effectively predict the safety of drugs and chemicals in humans."
Explore further: Team to use 'organ-on-a-chip' microdevices to evaluate therapies for lethal radiation exposure
Medical Xpress on facebook
Related Stories
Team to use 'organ-on-a-chip' microdevices to evaluate therapies for lethal radiation exposure
Aug 12, 2013
A team at the Wyss Institute for Biologically Inspired Engineering at Harvard University has received a $5.6 million grant award from the United States Food and Drug Administration (FDA) to use its Organs-on-Chips ...
Lung-on-a-Chip wins prize for potentially reducing need for animal testing
Feb 26, 2013
In a London ceremony today, Wyss Founding Director Don Ingber, M.D., Ph.D., received the NC3Rs 3Rs Prize from the UK's National Centre for the Replacement, Refinement and Reduction of Animals in Research ...
Scientists integrating multiple organ-on-chip systems to mimic the whole human body
Aug 11, 2012
The Wyss Institute for Biologically Inspired Engineering at Harvard University today announced that it has entered into a Cooperative Agreement worth up to $37 million with the Defense Advanced Research ...
Army, academia develop human-on-a-chip technology
Sep 30, 2013
There was a time when the thought of manufacturing organs in the laboratory was science fiction, but now that science is a reality. Army Scientists at the Edgewood Chemical Biological Center and academia ...
'Lung-on-a-chip' sets stage for next wave of research to replace animal testing
Nov 07, 2012
Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University have mimicked pulmonary edema in a microchip lined by living human cells, as reported today in the journal Science Tr ...
Recommended for you
New estimates give updated count of Iraq war deaths between 2003 and 2011
16 hours ago
During the U.S.-led invasion and occupation of Iraq from 2003 to 2011, for every three people killed by violence, two died as a result of the collapse of the infrustructure that supports health care, clean ...
J&J 3Q net rises slightly on higher medicine sales
17 hours ago
A big jump in prescription drug sales and continued recovery of Johnson & Johnson's beleaguered consumer health business in the third quarter helped the health care giant overcome a new problem: slumping sales of its medical ...
Radiation experts confirm polonium on Arafat clothing
Oct 14, 2013
Swiss radiation experts have confirmed they found traces of polonium on clothing used by Yasser Arafat which "support the possibility" the veteran Palestinian leader was poisoned.
Buttocks-enhancing procedures please patients, small study finds
Oct 11, 2013
(HealthDay)—Beyonce, Kim Kardashian and Jennifer Lopez have put ample backsides on some women's wish lists. And what nature forgot, plastic surgeons can provide with a buttocks augmentation.
Checklist developed to cut radiation exposure in children
Oct 11, 2013
(HealthDay)—A checklist has been developed to minimize radiation exposure to children during radiography; the checklist has been published in the October issue of the Journal of the American College of ...
Execution drugs spark controversy as supplies dwindle
Oct 11, 2013
The United States is turning to new drugs for lethal injections as supplies of the current standard dwindle, sparking lawsuits from death row prisoners that the changes will cause undue suffering.
User comments
© Medical Xpress 2011-2013, Phys.org network
0 comments:
Post a Comment